annotation.conf 7.1 KB

123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150
  1. # ~/public_html/brat/data/Nactem-AZ/Angiogenesis-1.5.5/
  2. # -*- Mode: Text; tab-width: 2; indent-tabs-mode: nil; coding: utf-8; -*-
  3. # vim:set ft=conf ts=2 sw=2 sts=2 autoindent:
  4. [entities]
  5. # Simple text-based definition of a hierarchial ontology of
  6. # (physical) entity types.
  7. !Anatomical_entity
  8. !Material_anatomical_entity
  9. Organism
  10. Organism_subdivision
  11. Anatomical_system
  12. Organ
  13. Multi-tissue_structure
  14. Tissue
  15. Cell
  16. Cellular_component
  17. Organism_substance
  18. Immaterial_anatomical_entity
  19. Developing_anatomical_structure
  20. --------------------
  21. Pathological_formation
  22. Cancer
  23. --------------------
  24. Gene_or_gene_product
  25. Simple_chemical
  26. --------------------
  27. Amino_acid
  28. Protein_domain_or_region
  29. DNA_domain_or_region
  30. [relations]
  31. # Simple text-based definition of a hierarchial ontology of
  32. # binary relation types.
  33. Equiv Arg1:Protein_domain_or_region, Arg2:Protein_domain_or_region, <REL-TYPE>:symmetric-transitive
  34. Equiv Arg1:DNA_domain_or_region, Arg2:DNA_domain_or_region, <REL-TYPE>:symmetric-transitive
  35. Equiv Arg1:Amino_acid, Arg2:Amino_acid, <REL-TYPE>:symmetric-transitive
  36. Equiv Arg1:Gene_or_gene_product, Arg2:Gene_or_gene_product, <REL-TYPE>:symmetric-transitive
  37. Equiv Arg1:Simple_chemical, Arg2:Simple_chemical, <REL-TYPE>:symmetric-transitive
  38. Equiv Arg1:Tissue, Arg2:Tissue, <REL-TYPE>:symmetric-transitive
  39. Equiv Arg1:Organism, Arg2:Organism, <REL-TYPE>:symmetric-transitive
  40. Equiv Arg1:Cell, Arg2:Cell, <REL-TYPE>:symmetric-transitive
  41. Equiv Arg1:Cellular_component, Arg2:Cellular_component, <REL-TYPE>:symmetric-transitive
  42. Equiv Arg1:Pathological_formation, Arg2:Pathological_formation, <REL-TYPE>:symmetric-transitive
  43. Equiv Arg1:Organism_substance, Arg2:Organism_substance, <REL-TYPE>:symmetric-transitive
  44. Equiv Arg1:Anatomical_system, Arg2:Anatomical_system, <REL-TYPE>:symmetric-transitive
  45. Equiv Arg1:Multi-tissue_structure, Arg2:Multi-tissue_structure, <REL-TYPE>:symmetric-transitive
  46. Equiv Arg1:Cancer, Arg2:Cancer, <REL-TYPE>:symmetric-transitive
  47. # Marks entities that are textually fragmented, as in e.g.
  48. # "alpha- and beta-catenin".
  49. frag Arg1:Gene_or_gene_product, Arg2:Gene_or_gene_product
  50. frag Arg1:Protein_domain_or_region, Arg2:Protein_domain_or_region
  51. frag Arg1:Tissue, Arg2:Tissue
  52. frag Arg1:Cell, Arg2:Cell
  53. frag Arg1:Organism, Arg2:Organism
  54. frag Arg1:Other_pharmaceutical_agent, Arg2:Other_pharmaceutical_agent
  55. frag Arg1:Simple_chemical, Arg2:Simple_chemical
  56. frag Arg1:Pathological_formation, Arg2:Pathological_formation
  57. frag Arg1:Multi-tissue_structure, Arg2:Multi-tissue_structure
  58. frag Arg1:Organism_subdivision, Arg2:Organism_subdivision
  59. frag Arg1:Cellular_component, Arg2:Cellular_component
  60. frag Arg1:Cancer, Arg2:Cancer
  61. # Permitted entity nestings. Defines which entity mention spans in
  62. # text can be contained in which by type. Arg1 identifies the type of
  63. # the inner, Arg2 the type of the outer entity.
  64. ENTITY-NESTING Arg1:Gene_or_gene_product, Arg2:Organism
  65. ENTITY-NESTING Arg1:Gene_or_gene_product, Arg2:Tissue
  66. ENTITY-NESTING Arg1:Gene_or_gene_product, Arg2:Cell
  67. ENTITY-NESTING Arg1:Gene_or_gene_product, Arg2:Pathological_formation
  68. ENTITY-NESTING Arg1:Gene_or_gene_product, Arg2:Cancer
  69. [events]
  70. # Simple text-based definition of a hierarchial ontology of event
  71. # types and their arguments.
  72. <MOLECULE>=Gene_or_gene_product|Simple_chemical|Amino_acid
  73. <ANATOMY>=Anatomical_entity|Material_anatomical_entity|Organism_subdivision|Organ_system|Anatomical_system|Organ|Multi-tissue_structure|Tissue|Cell|Cellular_component|Organism_substance|Immaterial_anatomical_entity|Embryonic_structure|Developing_anatomical_structure|Pathological_formation|Cancer
  74. !Protein_or_small_molecule_production_or_breakdown
  75. Metabolism Theme:Gene_or_gene_product|Simple_chemical|Amino_acid
  76. Gene_expression Theme+:Gene_or_gene_product
  77. Transcription Theme:Gene_or_gene_product
  78. Translation Theme:Gene_or_gene_product
  79. Protein_processing Theme:Gene_or_gene_product
  80. Synthesis Theme:Simple_chemical
  81. Catabolism Theme:Gene_or_gene_product|Simple_chemical
  82. Glycolysis Theme?:Simple_chemical
  83. Amino_acid_catabolism Theme?:Simple_chemical
  84. ---------
  85. !Cell_or_tissue_production_or_breakdown
  86. Development Theme:Organism|<ANATOMY>
  87. Blood_vessel_development Theme?:<ANATOMY>, AtLoc?:Organism|<ANATOMY>, ToLoc?:Organism|<ANATOMY>, FromLoc?:Organism|<ANATOMY>
  88. Growth Theme:Organism|<ANATOMY>
  89. Reproduction Theme:Organism
  90. Cell_proliferation Theme:Cell
  91. Cell_division Theme:Cell
  92. Cell_differentiation Theme?:Cell, AtLoc?:Cancer
  93. Remodeling Theme:<ANATOMY>
  94. Death Theme:Organism|<ANATOMY>
  95. Cell_death Theme?:Cell
  96. Breakdown Theme:<ANATOMY>
  97. ---------
  98. Mutation Theme?:Gene_or_gene_product|Cellular_component, Site?:DNA_domain_or_region|Protein_domain_or_region|Amino_acid, AtLoc?:<ANATOMY>
  99. Carcinogenesis Theme?:Cancer, AtLoc?:<ANATOMY>
  100. Cell_transformation Theme?:Cell, AtLoc?:<ANATOMY>
  101. Metastasis Theme?:Cancer|Cell, ToLoc?:<ANATOMY>
  102. Infection Theme?:<ANATOMY>|Organism, Participant?:Organism
  103. ---------
  104. !Macromolecule_modification
  105. Phosphorylation Theme:Gene_or_gene_product|Simple_chemical, Site?:Protein_domain_or_region|Amino_acid
  106. Dephosphorylation Theme:Gene_or_gene_product|Simple_chemical, Site?:Protein_domain_or_region|Amino_acid
  107. Methylation Theme:Gene_or_gene_product|Simple_chemical, Site?:Protein_domain_or_region|Amino_acid
  108. Demethylation Theme:Gene_or_gene_product|Simple_chemical, Site?:Protein_domain_or_region|Amino_acid
  109. Glycosylation Theme:Gene_or_gene_product|Simple_chemical, Site?:Protein_domain_or_region|Amino_acid
  110. Deglycosylation Theme:Gene_or_gene_product|Simple_chemical, Site?:Protein_domain_or_region|Amino_acid
  111. Ubiquitination Theme:Gene_or_gene_product|Simple_chemical, Site?:Protein_domain_or_region|Amino_acid
  112. Deubiquitination Theme:Gene_or_gene_product|Simple_chemical, Site?:Protein_domain_or_region|Amino_acid
  113. Acetylation Theme:Gene_or_gene_product|Simple_chemical, Site?:Protein_domain_or_region|Amino_acid
  114. Deacetylation Theme:Gene_or_gene_product|Simple_chemical, Site?:Protein_domain_or_region|Amino_acid
  115. DNA_methylation Theme:Gene_or_gene_product|Cellular_component, Site?:DNA_domain_or_region
  116. DNA_demethylation Theme:Gene_or_gene_product|Cellular_component, Site?:DNA_domain_or_region
  117. ---------
  118. !General_biomolecular_events
  119. Binding Theme+:<MOLECULE>|<ANATOMY>, Site?:Protein_domain_or_region|Amino_acid|DNA_domain_or_region
  120. Dissociation Theme+:<MOLECULE>|<ANATOMY>
  121. Localization Theme+:<MOLECULE>|<ANATOMY>, ToLoc?:<ANATOMY>, AtLoc?:<ANATOMY>, FromLoc?:<ANATOMY>
  122. ---------
  123. !Regulation_and_general_causality
  124. Regulation Theme:<ENTITY>|<EVENT>, Cause?:<ENTITY>|<EVENT>, Site?:Protein_domain_or_region|Amino_acid|DNA_domain_or_region, CSite?:Protein_domain_or_region|Amino_acid|DNA_domain_or_region
  125. Positive_regulation Theme:<ENTITY>|<EVENT>, Cause?:<ENTITY>|<EVENT>, Site?:Protein_domain_or_region|Amino_acid|DNA_domain_or_region, CSite?:Protein_domain_or_region|Amino_acid|DNA_domain_or_region
  126. Negative_regulation Theme:<ENTITY>|<EVENT>, Cause?:<ENTITY>|<EVENT>, Site?:Protein_domain_or_region|Amino_acid|DNA_domain_or_region, CSite?:Protein_domain_or_region|Amino_acid|DNA_domain_or_region
  127. ---------
  128. !Experimental_intervention
  129. Planned_process Theme*:<ENTITY>|Blood_vessel_development, Instrument*:<ENTITY>
  130. --------------------
  131. Pathway Participant*:<ENTITY>
  132. [attributes]
  133. Negation Arg:<EVENT>
  134. Speculation Arg:<EVENT>